Myriad Genetics, Inc. (MYGN)
NASDAQ: MYGN · Real-Time Price · USD
6.75
+0.29 (4.49%)
Nov 5, 2025, 10:28 AM EST - Market open
Myriad Genetics Analyst Ratings
Total Analysts
14
Consensus Rating
Hold
Price Target
$13.27
Upside
+96.59%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Hold Maintains $6 → $6.5 | Hold | Maintains | $6 → $6.5 | -3.70% | Nov 5, 2025 |
| TD Cowen | TD Cowen | Hold Maintains $8 → $9 | Hold | Maintains | $8 → $9 | +33.33% | Nov 4, 2025 |
| UBS | UBS | Hold Maintains $6 → $8 | Hold | Maintains | $6 → $8 | +18.52% | Nov 4, 2025 |
| Scotiabank | Scotiabank | Buy → Hold Downgrades $20 → $6 | Buy → Hold | Downgrades | $20 → $6 | -11.11% | May 21, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $13 → $9 | Buy | Maintains | $13 → $9 | +33.33% | May 15, 2025 |
| Wells Fargo | Wells Fargo | Buy → Hold Downgrades $22 → $6 | Buy → Hold | Downgrades | $22 → $6 | -11.11% | May 8, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $14 → $8 | Strong Buy | Maintains | $14 → $8 | +18.52% | May 7, 2025 |
| UBS | UBS | Hold Maintains $16 → $7 | Hold | Maintains | $16 → $7 | +3.70% | May 7, 2025 |
| Raymond James | Raymond James | Buy Reiterates $19 → $10 | Buy | Reiterates | $19 → $10 | +48.15% | May 7, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $18 → $14 | Strong Buy | Maintains | $18 → $14 | +107.41% | Apr 17, 2025 |
| Guggenheim | Guggenheim | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Apr 9, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $24 → $20 | Buy | Maintains | $24 → $20 | +196.30% | Apr 1, 2025 |
| Piper Sandler | Piper Sandler | Hold → Buy Upgrades $12 → $13 | Hold → Buy | Upgrades | $12 → $13 | +85.19% | Mar 12, 2025 |
| Piper Sandler | Piper Sandler | Hold Maintains $14 → $12 | Hold | Maintains | $14 → $12 | +70.37% | Mar 4, 2025 |
| B of A Securities | B of A Securities | Sell Maintains $13 → $11 | Sell | Maintains | $13 → $11 | +62.96% | Mar 3, 2025 |
| Raymond James | Raymond James | Buy Reiterates $27 → $19 | Buy | Reiterates | $27 → $19 | +181.48% | Feb 25, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.